BackNabriva Therapeutics Plc Overview
Nabriva Therapeutics Plc

Nabriva Therapeutics Plc Target Price

See how NBRV's target price trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Share Price

$1.42

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2023-01-06Northland SecuritiesCarl Byrnes$129.6% downsideOpen

Nabriva Therapeutics Plc (NBRV) FAQ

Stockcircle tracks target price for Nabriva Therapeutics Plc (NBRV), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Nabriva Therapeutics Plc's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main NBRV overview so you can move from this figure to the surrounding analysis quickly.